Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: protocol for a nationwide observational comparative study in routine care

Authors

L. Vigié
Camille Nevoret (ORCID: https://orcid.org/0000-0002-5485-1535)
B. Detournay (ORCID: https://orcid.org/0000-0001-7843-4608)
François Schiele (ORCID: https://orcid.org/0000-0003-4974-6551)
Nicolas Danchin (ORCID: https://orcid.org/0000-0001-9263-5051)
Gilles Lemesle (ORCID: https://orcid.org/0000-0002-2917-9273)
Kamel Mohammedi (ORCID: https://orcid.org/0000-0001-6139-1197)
Alexandre Caron (ORCID: https://orcid.org/0000-0002-9872-0633)
Laurent Fauchier (ORCID: https://orcid.org/0000-0002-9267-1658)
Corinne Emery (ORCID: https://orcid.org/0000-0002-7333-0567)
Mikaël Mazighi (ORCID: https://orcid.org/0000-0003-0911-8999)
Christine Massien
Igor Sibon (ORCID: https://orcid.org/0000-0002-1171-4215)

Institutions

Université de Tours (FR)
Université de Bordeaux (FR)
Inserm (FR)
Université Paris Cité (FR)
Université de Lille (FR)
Institut Pasteur de Lille (FR)
Centre Hospitalier Universitaire de Bordeaux (FR)
Centre Hospitalier Universitaire de Besançon (FR)
Cemka-Eval (France) (FR)
Centre Hospitalier Universitaire de Tours (FR)
Assistance Publique – Hôpitaux de Paris (FR)
Hôpital Européen Georges-Pompidou (FR)
Hôpital Européen (FR)
Hôpital Lariboisière (FR)
FHU Neurovasc (FR)
Alliance nationale pour les sciences de la vie et de la santé (FR)
Université de Franche-Comté (FR)

Publication Details

Journal: BMJ Open
Published: 2025-01-01
DOI: https://doi.org/10.1136/bmjopen-2024-087790
Citations: 1
Primary Topic: Diabetes Treatment and Management
Type: article
Field-Weighted Citation Impact: 1.29

Funders

Novo Nordisk

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: protocol for a nationwide observational comparative study in routine care

L. Vigié, Camille Nevoret, B. Detournay, François Schiele et al.

Jan 1, 2025

1 citations

BMJ Open

Diabetes Treatment and Management

1.29

article

Cardiovascular risk associated with glucagon-like peptide-1 receptor agonists versus other conventional glucose-lowering drugs in patients with type-2 diabetes: protocol for a nationwide observational comparative study in routine care

L. Vigié, Camille Nevoret, B. Detournay, François Schiele, Nicolas Danchin, Gilles Lemesle, Kamel Mohammedi, Alexandre Caron, Laurent Fauchier, Corinne Emery, Mikaël Mazighi, Christine Massien, Igor Sibon

January 1, 2025article en

1 citations

Abstract

No abstract available for this paper.

BMJ OpenVol. 15(1)

Université de Tours (FR), Université de Bordeaux (FR), Inserm (FR), Université Paris Cité (FR), Université de Lille (FR), Institut Pasteur de Lille (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Besançon (FR), Cemka-Eval (France) (FR), Centre Hospitalier Universitaire de Tours (FR), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Européen Georges-Pompidou (FR), Hôpital Européen (FR), Hôpital Lariboisière (FR), FHU Neurovasc (FR), Alliance nationale pour les sciences de la vie et de la santé (FR), Université de Franche-Comté (FR)

Novo Nordisk

Good health and well-being

Openalex Percentile: Top 24%

Diabetes Treatment and Management

1.29

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.